克唑替尼在ALK阳性晚期NSCLC患者中的疗效和安全性评价及其预后影响因素
梁红格, 徐燕钟, 巍赵静, 陈闽江, 王华竹, 王孟昭
Evaluation of efficacy and safety of crizotinib and its prognostic factors in patients with ALKpositive advanced nonsmall cell lung cancer
LIANG Hong-Ge, XU Yan-Zhong, WEI Zhao-Jing, CHEN Min-Jiang, WANG Hua-Zhu, WANG Meng-Zhao
国际肿瘤学杂志
.
2017, (5): 336
-341
.
DOI: 10.3760/cma.j.issn.1673422X.2017.05.004
